Member Info for MisterPositive

Some folks keep banging on about funding. We already got funding mechanism in place albiet not the best option chosen by them at the time.

Best option would have been issuing say 50m shares around 20p when we touched 43p. Since then it has fallen to 5p.

Having said that we can also have incoming partner injecting Investment Capital in return for future Royalties from sales enabling GDR to cancel current Riverfort finance deal.

You could then see a Massive jump in price towards 35p - 40p range in Double quick time.

Full NHS rollout should also bring in strong revenue from UK alone. Then add revenues from Europe and Middle East. So i see MASSIVE Upside and ROI from 5p.

CEO James Cheek previous roles and contacts at ROCHE, CEPHID, Beckman Coulter (Danaher Corp) should bring collaboration/ partner deals in near term.

Revenues should soon kick in from Distribution deals across Europe & Middle East. Additional Revenues from NHS roll out also.

See no reason why we cannot revisit +43p or higher touched in March 2023. We are lot more advanced now than 1 year ago. Current funding deal in place could be terminated immediately soon as Revenues start coming in OR incoming Partner injects Investment Capital in return for Royalties.

Incoming FDA partner providing funding for a slice of Royalties would be a very smart move in my view and very strong possibility going down this route. Win / Win for all parties.

Genedrive gaining lot of attention in USA. Any NASDAQ listed bio-tech could be one of the interested parties. Will find out soon.

Genedrive defo getting attention and coverage across Middle East, Europe and USA.

Positive news due on "Multiple" fronts.

Sales distribution partnership Deal(s).

FDA partner update (USA)

NICE recommendation & NHS roll out (UK)

AIHL and STROKE tests - updates

Target market Worldwide worth Billions $$$

GDR on watchlist of many and is one of those stocks that can jump from 5p to 50p real fast.

Lionel.

That is an excellent article highlighting pharmacogenetics as the future. Quote below:

"This represents a new paradigm in healthcare, moving away from the established one-size-fits-all approach to a more precise, bespoke prescribing strategy based on a person’s individual genetic profile."

Both AIHL and Stroke tests developed by Genedrive Plc are going to be game changer for the Healthcare Industry globally target a market worth $$$ Billions worldwide.

Jimi.

That is very good article. Genedrive getting lot of exposure in USA.

FDA news not far now. MMs trying to collect few on the cheap ahead of news.

We must also be close on partnership deals in both Europe and The Middle East.

Plus the £10m Govt backed funding deal.

Updates on Stroke tests also to look forward to.

Current MCap of £6m only is at rock bottom. News expected on "Multiple" fronts. This can easily rocket to £60m - £75m MCap in a heartbeat on positive update.

US partner deal cannot be far now.

Add on top of that - UAE (Dubai & Abu Dhabi) , Qatar and wider Middle-East product marketing & distribution deals.

Managed to get some now after few attempts.

Current MCap of only £7m is so ridiculous.

NHS contracts alone could be 10 x times that.

Cannot buy more than £100 worth ??

What is going on here !!! About to move higher.

Ridiculously cheap with news about to land.

Time to load up now while still at the lows before it rockets higher. We all know how fast it moves.

Very positive update on NICE earlier this week. Full roll out across entire NHS just a matter of time. All looking very good especially from such a lower entry price. Dont be in that camp who later regret, could have / should have bought at 5p. Good luck all.

We entering busy News flow period soon both on GRE/ARV JV front - Osborne / Kobe.

Artemis also busy at Mt Marie (100% ARV) with ongoing rock chip sampling. Further updates due

At Osborne JV project they just tested the outskirts of the main body and still reported grades with similar geology and mineralisation found at Azure Minerals - Andover licence.

Large Spodumene crystals found at Artemis 100% Mt Marie licence are same as found on Andover discovery.

Artemis Resources got massive upside from both Mt Marie (100%) and Osborne JV with GRE.

Both GRE and ARV have got to be on the radar of the bigger players being next door to Azure Minerals and on same ground. Azure being bought for A$1.76 billion via joint bid from SQM and Gina Rinehart.

Time to add / Accumulate while still cheap. IMO

Way OVERSOLD.

Drop in AUS was 15%...drop in London 40% ??

Trading halt related to Osborne JV between GRE and ARV. In my opinion trading halt was not needed. Osborne results were good but in all that suspense some folks just sold out of frustration. Not sure what they expected.

In all that suspense, our 100% owned Mt Marie significant Lithium discovery with similar pegmatite crystals found just like at Azure Minerals (subject to A$1.8 billion takeover) got overlooked completely.

I doubled my holding here on this temporary drop. Once folks calm down, market will realise we got MASSIVE UPSIDE here.

Importantly for the Company and the region, this discovery is further evidence of a potential corridor of lithium mineralisation extending beyond 40km in the west Pilbara region, where Artemis' tenements are located.

Reminds me of Solgold which went from 1p to 45p around 10-12 years ago when NewCrest and BHP piled in due to size of the discovery at the time.

Why is everyone replying on the negative thread.

That is what these fekkers want.

Need to reply on positive thread to counter their negativity.

Took advantage of the temporary pullback to add few more.

Current MCap here is ridiculous compared to where it could be sitting in coming months using Azure A$1.8 billion as a proxy for Buy Out valuation.

Albiet Azure is a year ahead but was floating at the bottom before their Lithium discovery and then A$1.8 billion takeover price tag.

11.2p price target was before Spodumene Lithium discovery at MARIE deposit (100% ARV).

Revised price target in my opinion should be lot higher than 11.2p. Just look at the A$1.8Billion buyout of Azure Minerals next door to us more recently.

Great work news. Lots of useful info. Thanks.

Artemis & Greentech in great place now sitting on the largest licence in the Andover complex next door to Azure Minerals.

Big players now showing interest in what else is available after A$1.8 billion buy out of Azure.

Expecting price to more than Double next week as market plays catch up and realises how significantly undervalued Artemis is.

MARIE lithium deposit is 100% Artemis ground. Add to this other deposits Artemis has 49% JV with GreenTech etc.

Still cannot get over how AZURE Minerals stormed from circa A$100m to A$1.76 Billion MCap. Amazing returns for Azure investors. Success here would push Artemis to NEW HIGHS. Stay put here is best strategy in my opinion.

Expect fireworks next week.

ARV is so UNDERVALUED....its crazy !!